Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Timothy E. Graham(Diabetes & Endocrinology Specialists), Barbara B. Kahn(Beth Israel Deaconess Medical Center), Theodore P. Ciaraldi(University of California San Diego), Robert R. Henry(United States Department of Veterans Affairs), Christopher J. Wason(Beth Israel Deaconess Medical Center), Qin Yang(Anhui Medical University), Ann Hammarstedt(AstraZeneca (Sweden)), Matthias Blüher(Leipzig University), Andreas Oberbach(Johns Hopkins Hospital), Per‐Anders Jansson, Ulf Smith(University of Gothenburg)
Cited by 1,310
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k